US Patent Issued to BAYER on May 5 for "Crystallisation-free, highly concentrated suspension concentrates of metribuzin and diflufenican" (German Inventor)

ALEXANDRIA, Va., May 5 -- United States Patent no. 12,616,199, issued on May 5, was assigned to BAYER AG (Leverkusen, Germany).

"Crystallisation-free, highly concentrated suspension concentrates of metribuzin and diflufenican" was invented by Arianna Martelletti (Sulzbach im Taunus, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the technical field of surfactant combinations combined with rheological modifiers combinations for crop protection formulations with increased shelf life and reduced crystallization, in particular herbicidal formulations, and formulations containing said surfactant combinations, as well as methods for producing said formulations."

The patent was fil...